Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Results Interpretation and Post-Test Actions – Nu.Q® Vet Cancer Test

Saturday, April 5, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article serves as a guide for veterinarians on interpreting the results of the Nu.Q® Vet Cancer Test and outlines recommended post-test actions. It highlights the potential financial benefits tied to the publication of a related study in a peer-reviewed journal. Additionally, it mentions the launch of the first automated version of the test in collaboration with Fujifilm Vet Systems.
Price reaction · baseline $10.646 (2025-04-04 close) · 2 other VNRX headline(s) in the window, move may be shared
day 0 close
-6.1%
day 1 · peak
-13.6%
day 3
-9.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • The Nu.Q® Vet Cancer Test provides valuable guidance for veterinarians.
  • A peer-reviewed publication may unlock a significant financial milestone.
  • The introduction of an automated version of the test enhances accessibility.

Full Press Release Details

A guide for veterinarians to interpret results of the Nu.Q ® Vet Cancer Test and recommended post-test actions.

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is a diagnostic tool designed to help veterinarians detect cancer in pets.

What are the recommended actions after testing?

Veterinarians are guided on interpreting test results and suggested post-test actions.

How does the automated test improve the process?

The automated version of the test enhances accessibility and efficiency for veterinarians.

What financial milestone is associated with the test?

The publication of a related study may unlock a $5 million contractual milestone payment.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Nu.Q Vet Cancer Test veterinary oncology cancer detection Fujifilm Vet Systems
Last updated: Apr 5, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk